Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01941784 · ClinicalTrials.gov registry record · NA
Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT01941784 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 28 participants.
The verdict
NCT01941784, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
This pilot clinical trial studies a health education intervention in reducing weight gain in patients with newly diagnosed stage I-IV breast cancer undergoing chemotherapy. A health education program may reduce weight gain and improve quality of life in patients undergoing chemotherapy for breast cancer.
Interventions
- OTHER questionnaire administration
- PROCEDURE quality-of-life assessment
- OTHER educational intervention
- OTHER counseling intervention
- BEHAVIORAL telephone-based intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2013-11-25 |
| Est. Completion | 2017-04-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01941784
The ClinicalTrials.gov registry entry for NCT01941784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which questionnaire administration is the first listed.
NCT01941784 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01941784 about?
NCT01941784 is a clinical study titled "Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy". This pilot clinical trial studies a health education intervention in reducing weight gain in patients with newly diagnosed stage I-IV breast cancer undergoing chemotherapy. A health education program may reduce weight gain and improve quality of life in patients undergoing chemotherapy for breast ca...
What is the current status of trial NCT01941784?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2013-11-25. Estimated completion is 2017-04-12.
What interventions are being tested in trial NCT01941784?
The interventions under investigation include: questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), educational intervention (OTHER), counseling intervention (OTHER), telephone-based intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01941784?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.